COMMUNIQUÉS West-GlobeNewswire

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
06/06/2018
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR ENRICHMENT WITH [...]
Matinas BioPharma to Present Preclinical Data at ASM Microbe 2018 Further Demonstrating the Broad Utility of its LNC Platform
06/06/2018
Data demonstrate safe, effective oral delivery of antimicrobial drugs utilizing LNC technology BEDMINSTER, N.J., June 06, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage [...]
Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference
06/06/2018
DUBLIN, Ireland and TREVOSE, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
eFFECTOR Initiates Dosing of eFT508 in Phase 2 Expansion of Clinical Trial in Aggressive Form of Non-Hodgkin’s Lymphoma
06/06/2018
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that it has dosed the first [...]
Metacrine Completes $65 Million Series C Financing
06/06/2018
Proceeds will support clinical development of FXR program in NASH and GI diseases SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit [...]
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
06/06/2018
SALT LAKE CITY, June 06, 2018 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that data on the use of the Vectra ® DA test will be presented at [...]
CMS Rating for Amedisys Home Health Rises to 32 Percent Above the National Average
06/06/2018
BATON ROUGE, La., June 06, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, received an average rating of 4.30 Stars out of a [...]
Dr. Sherrell J. Aston is One of the First to Offer New Groundbreaking EmbraceRF Procedure
06/06/2018
NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Dr. Sherrell J. Aston introduces EmbraceRF, a new facial contouring technique that addresses a treatment gap in current modalities offered to patients. EmbraceRF provides the [...]
T2 Biosystems Reports Granting of Inducement Awards
06/06/2018
LEXINGTON, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Acasti Pharma to Present at the XVIII(th) International Symposium on Atherosclerosis
06/06/2018
LAVAL, Québec, June 06, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST) (the “ Company ” or “ Acasti Pharma ”), a biopharmaceutical innovator focused on the research, development and [...]
Cannabis Wheaton Income Corp. Announces Proposed Change of Name
06/06/2018
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") is pleased to announce that the Company intends to change its name to " [...]
Intra-Cellular Therapies Initiates Rolling Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia
06/06/2018
NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
BeiGene to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
CAMBRIDGE, Mass., and BEIJING, China, June 06, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted [...]
The Alliance for Regenerative Medicine Launches Foundation to Promote Understanding and Acceptance of Potentially Curative Cell and Gene Therapies
06/06/2018
Non-profit will educate, engage, and empower patients, caregivers, scientists, and industry leaders WASHINGTON, DC, June 06, 2018 (GLOBE NEWSWIRE) -- As part of its ongoing efforts to accelerate patient access to safe, [...]
BioCorRx Raises $1.1 Million at Premium to Market
06/06/2018
ANAHEIM, CA, June 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced the Company [...]
AxoGen, Inc. to Present at Upcoming Investor Conferences
06/06/2018
William Blair 38 th Annual Growth Stock Conference, June 14 JMP Securities Life Sciences Conference, June 20 ALACHUA, Fla., June 06, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]
InMode Aesthetic Solutions Launches A New Concept for Subdermal Adipose-Remodeling of the Face, EmbraceRF and Morpheus8
06/06/2018
LAKE FOREST, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- InMode Aesthetic Solutions, the leader in cutting edge aesthetic medicine and technology solutions introduces EmbraceRF, a new facial contouring technique that [...]
Nightstar Therapeutics Reports First Quarter 2018 Financial Results and Acceleration of Preliminary NSR-RPGR Readout to Third Quarter 2018
06/06/2018
Preliminary data from dose escalation study in the Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigmentosa expected ahead of schedule in Q3 2018 Dose expansion study in the XIRIUS trial expected to begin enrollment in [...]
RavenQuest Announces Letter of Intent to Purchase Western Agripharma Ltd.
06/06/2018
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (the “ Company ” or “ RavenQuest ”) is pleased to announce that it has entered into a binding letter of intent with Western [...]

Pages